Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Frankfurt - Delayed Quote EUR

PT Multi Indocitra Tbk (QF9.F)

Compare
0.0175
+0.0035
+(25.00%)
At close: April 4 at 8:13:02 AM GMT+2
Loading Chart for QF9.F
  • Previous Close 0.0140
  • Open 0.0175
  • Bid 0.0200 x 30000000
  • Ask 0.0335 x 30000000
  • Day's Range 0.0175 - 0.0175
  • 52 Week Range 0.0140 - 0.0255
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) 13.914M
  • Beta (5Y Monthly) 0.25
  • PE Ratio (TTM)
  • EPS (TTM) 0.0000
  • Earnings Date --
  • Forward Dividend & Yield 0.00 (3.22%)
  • Ex-Dividend Date Jul 4, 2024
  • 1y Target Est --

PT Multi Indocitra Tbk produces and distributes baby and health care products, and cosmetics in Indonesia. The company distributes personal care, household, baby, and other consumer goods. It also involved in the distribution, warehousing, and transportation service; retail sale of baby; manufacturing baby products, such as nursing bottle, nipple, and baby accessories under Pigeon brand. In addition, the company provides e-commerce enabler and marketing agency; and logistics services. The company was founded in 1990 and is headquartered in Jakarta Barat, Indonesia.

www.mic.co.id

396

Full Time Employees

December 31

Fiscal Year Ends

Recent News: QF9.F

View More

Performance Overview: QF9.F

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is IDX COMPOSITE (^JKSE) .

YTD Return

QF9.F
20.45%
IDX COMPOSITE (^JKSE)
8.04%

1-Year Return

QF9.F
100.16%
IDX COMPOSITE (^JKSE)
10.25%

3-Year Return

QF9.F
100.00%
IDX COMPOSITE (^JKSE)
8.51%

5-Year Return

QF9.F
100.00%
IDX COMPOSITE (^JKSE)
40.82%

Compare To: QF9.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: QF9.F

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    13.91M

  • Enterprise Value

    26.14M

  • Trailing P/E

    4.96

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.17

  • Price/Book (mrq)

    0.21

  • Enterprise Value/Revenue

    0.44

  • Enterprise Value/EBITDA

    4.81

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.77%

  • Return on Assets (ttm)

    3.57%

  • Return on Equity (ttm)

    4.63%

  • Revenue (ttm)

    1.12T

  • Net Income Avi to Common (ttm)

    42.13B

  • Diluted EPS (ttm)

    0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    81.87B

  • Total Debt/Equity (mrq)

    32.60%

  • Levered Free Cash Flow (ttm)

    2.14B

Research Analysis: QF9.F

View More

Company Insights: QF9.F

Research Reports: QF9.F

View More

People Also Watch